Mutations in the H7 HA and PB1 genes of avian influenza a viruses increase viral pathogenicity and contact transmission in guinea pigs

Emerg Microbes Infect. 2019;8(1):1324-1336. doi: 10.1080/22221751.2019.1663131.

Abstract

Avian influenza A viruses (AIV) of the H7 subtype continue to evolve posing a pandemic threat. However, molecular markers of H7N7 AIV pathogenicity and transmission in mammals remain poorly understood. In this study, we performed a systematic in vitro and in vivo analysis by comparing an H7N7 highly pathogenic AIV and its ferret adapted variant. Passaging an H7N7 AIV in ferrets led to six mutations in genes encoding the viral polymerase complex and the viral surface proteins. Here, we show that mutations in the H7 hemagglutinin gene cause increased pathogenicity in mice. Contact transmission between guinea pigs required additional mutations in the gene encoding the polymerase subunit PB1. Thus, particular vigilance is required with respect to HA and PB1 mutations as predictive molecular markers to assess the pandemic risk posed by emerging H7 avian influenza viruses.

Keywords: H7 avian influenza A viruses; HA and PB1 gene mutations; guinea pigs; pathogenicity; transmission.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Disease Transmission, Infectious*
  • Ferrets
  • Guinea Pigs
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics*
  • Influenza A Virus, H7N7 Subtype / genetics
  • Influenza A Virus, H7N7 Subtype / pathogenicity*
  • Mutant Proteins / genetics*
  • Orthomyxoviridae Infections / pathology
  • Orthomyxoviridae Infections / transmission*
  • Orthomyxoviridae Infections / virology*
  • Serial Passage
  • Viral Proteins / genetics*
  • Virulence Factors / genetics

Substances

  • Hemagglutinin Glycoproteins, Influenza Virus
  • Mutant Proteins
  • Viral Proteins
  • Virulence Factors
  • influenza virus polymerase basic protein 1

Grants and funding

The doctoral study of Carola Dreier was funded by the graduate school of the Leibniz Center Infection (LCI). This work was additionally supported by the Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, which is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health.